Gyros Protein Systems AB, a leading supplier of peptide synthesizers and reagents, and a pioneer in automated nanoliter-scale immunoassays, currently introduced the launch of 3 company choices to support advancement and manufacturing of peptide-centered medications. The new products and services are primarily based on the Company’s PurePep® EasyClean (PEC) orthogonal peptide purification technological know-how.
The new solutions include things like:
- “PEC-grade peptide service” – for personalized synthesis of PEC-grade peptides
- “Custom PEC system and kit development” – for scale-up and scale-out of the technology, and
- “Enabling new modalities manufacturing with PEC” – to speed up the developments of novel and complicated peptide-centered drug modalities.
The providers are supported by two present PEC kit sorts: the “Starter Kits” and “High Throughput Kits”.
PEC orthogonal peptide purification know-how represents a easy catch-and-launch answer to conquer bottlenecks in peptide-primarily based drug enhancement, such as higher throughput purification of peptides for responsible preclinical testing, scale-up and production of intricate peptide prescription drugs. PEC is a environmentally friendly chemistry solution, which considerably minimizes the need for natural and organic solvents by up to 95%.
The PEC know-how is now thoroughly built-in into Gyros Protein Technologies’ presenting, via two package varieties and the freshly introduced services, next the Company’s acquisition of Belyntic’s peptide purification small business in November 2022. The integration usually means Gyros Protein Technologies is now capable to assistance buyers all through the full workflow, from synthesis to closing purified item, accelerating drug enhancement and producing procedures.
“With the integration of Belyntic’s best-in-course orthogonal purification know-how and introduction of the new services, we are equipped to add benefit as a result of complete workflow remedies, accelerating peptide-primarily based drug progress and production procedures. We also welcome Dr. Robert Zitterbart to travel item and provider development for this side of the company.”
Mark Vossenaar, Standard Manager, Biopharmaceutical Improvement Division, Gyros Protein Systems
Dr. Robert Zitterbart, inventor of PEC and now Director R&D PEC Services, Gyros Protein Systems, reported: “We are delighted to now offer the new solutions based mostly on the PEC technology, which correctly complement the Starter Kits and Superior Throughput Kits, and we are hunting ahead to doing work with clients to support conquer their challenges in peptide-dependent drug development and production.”